当前位置: 首页 >> 检索结果
4232. WITHDRAWN: A Rare Cause of Peri-esophageal Cystic Lesion.
This article has been retracted: please see Elsevier policy on article withdrawal (https://www.elsevier.com/about/policies-and-standards/article-withdrawal). This article has been retracted at the request of the Editors-in-Chief. The article is a duplicate of a paper that has already been published in Natl Med J China, 第551例 吞咽困难—胸腔积液—后纵隔囊肿, Vol 101, No. 48, 3977-3980. Redundant publications overweigh the relative importance of published findings and distort the academic record of the authors. One of the conditions of submission of a paper for publication is therefore that authors declare explicitly that the paper has not been previously published and is not under consideration for publication elsewhere. As such, this article represents a misuse of the scientific publishing system. The Publisher reached out to the authors for an explanation, but they did not respond.
4234. Alcohol use disorder identification test renamed Glu-Glu Test in an area of north-west of Italy: preliminary descriptive results.
作者: Patrizia Balbinot.;Carlo L Bottaro.;Nicoletta Gandolfo.;Rinaldo Pellicano.;Gianni Testino.
来源: Minerva Gastroenterol (Torino). 2023年69卷4期517-522页
The first two causes of liver cirrhosis and hepatocellular carcinoma are alcoholic and dysmetabolic. In the early stages alcohol related liver disease (ALD) is silent. For this reason, more efforts should be made to identify early individuals with hazardous/harmful alcohol consumption (AC). Alcohol use disorder identification test (AUDIT) is a validated test.
4240. Regulatory and Clinical Expert Perspective of the 2022 FDA Draft Guidance "Celiac Disease: Developing Drugs for Adjunctive Treatment to a Gluten-Free Diet". |